Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer
Sponsor
Institut Universitari Dexeus (Other)
Overall Status
Completed
CT.gov ID
NCT02323347
Collaborator
(none)
1,901
61.9
Study Details
Study Description
Brief Summary
At which deleterious cut off value of progesterone on day of HCG (P-hCG) in our IVF program should fresh embryo transfer (ET) be cancelled?
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
There is still an ongoing debate on the effect of subtle increased P-hCG concentration on pregnancy outcome after fresh ET. No consensus on the cut-off value to define increased P-hCG seems to exist. It is accepted that high P advances endometrium, leading to asynchrony between the implanting embryo and the endometrium, and resulting in implantation failure. A freeze all embryos policy and postponement of ET in subsequent frozen-thawed cycle has been proposed.
Study Design
Study Type:
Observational
Actual Enrollment
:
1901 participants
Observational Model:
Case-Crossover
Time Perspective:
Retrospective
Official Title:
Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer
Study Start Date
:
Jan 1, 2009
Actual Primary Completion Date
:
Mar 1, 2014
Actual Study Completion Date
:
Mar 1, 2014
Outcome Measures
Primary Outcome Measures
- Clinical Pregnancy [6 weeks after embryo transfer procedure]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Fresh embryo transfer
-
Progesterone value on day HCG (Human choriogonadotrophin hormone)
Exclusion Criteria:
- Clinical indication for delaying embryo transfer
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Institut Universitari Dexeus
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Dr. Francisca MartÃnez,
PhD,
Institut Universitari Dexeus
ClinicalTrials.gov Identifier:
NCT02323347
Other Study ID Numbers:
- PROGEDEX2014
First Posted:
Dec 23, 2014
Last Update Posted:
Dec 23, 2014
Last Verified:
Dec 1, 2014